Bank Of Montreal Cor Medix Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$2.81 - $4.45 $281,030 - $445,048	100,011 Added 53.51%	286,900 $1.21 Million
Q3 2022 Nov 10, 2022	SELL	$2.82 - $7.52 $267,085 - $712,226	-94,711 Reduced 33.63%	186,889 $587,000
Q2 2022 Aug 11, 2022	BUY	$2.73 - $5.61 $768,768 - $1.58 Million	281,600 New	281,600 $1.02 Million

118

17.9M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $419M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.